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 large  port-site  metastases  of  extrahepatic  cholangiocarcinoma  after
aparoscopic  cholecystectomy
na gran metástasis en sitio de puerto de un colangiocarcinoma extrahepático tras
olecistecomía laparoscópica
arlos  Eduardo  Salazar-Mejía ∗Alan  Burguete-Torres
astrointestinal Tumors Unit, Centro Universitario Contra el Cáncer, University Hospital “Dr. José Eleuterio González” and Faculty of Medicine, Universidad Autónoma de Nuevo León,
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Fig. 1.
A 45-year-old female was sent for a second opinion to the Gastrointestinal Tumors Unit at our institution with a diagnosis of progressive,
etastatic cholangiocarcinoma. Her present illness begun 10 months ago, when an extrahepatic cholangiocarcinoma was incidentally found
uring ERCP for residual choledocholithiasis after primary laparoscopic cholecystectomy. Additional imaging studies showed non-regional
ymph node and port-site tract metastases. The patient received first-line combination chemotherapy with gemcitabine–cisplatin and later
howed progressive disease in the abdominal wall after 8 cycles of treatment. She was then treated with capecitabine–oxaliplatin for 4-
ycles after which a CT scan demonstrated abdominal wall progression. At her first visit to our institution, the physical exam showed
 large, 15 × 20 cm tumor in the right upper abdomen extending to the epigastrium, below the port-insertion site scar (Fig. 1). After a
ultidisciplinary team discussion, further systemic treatment with combination 5-FU and irinotecan chemotherapy was offered.
Given that some patients with biliary tract cancer are diagnosed incidentally after laparoscopic cholecystectomy, port-site dissemination
rom tumor seeding is a risk to consider. Although port-site metastases have been associated to diffuse peritoneal recurrence and a poor
rognosis, the benefit of port-insertion site primary resection in terms of overall survival remains unknown.
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